What is Valganciclovir?

Category: Prescription Drugs

Most popular types: Valcyte

false

Valganciclovir is an antiviral agent used to treat cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome, and prevention of CMV disease in high-risk patients undergoing kidney, heart, or kidney/pancreas transplantation.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Prevent infection 45 16
Cytomegalovirus 11 2
Myalgic encephalomyelitis/chronic fatigue syndrome 11 5
Kidney transplant 5 1
Chronic Epstein-Barr 2 1

Show all 13 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 1
Mild 9
None 23

Commonly reported side effects and conditions associated with Valganciclovir

Side effect Patients
Chronic diarrhea 2
Diarrhea 1
Fatigue 1
Increased MCV and MCH 1
Liver impairment 1
Nausea 1

Show all 7 reported side effects

Dosages

Based on patients currently taking Valganciclovir

Dosage Patients
450 mg twice daily 2
900 mg daily 2

Why patients stopped taking Valganciclovir

Multiple reasons could be selected

Reason Patients
Course of treatment ended 23
Doctor's advice 17
Other 4
Did not seem to work 1
Expense 1
Side effects too severe 1
See all 39 patients who've stopped taking Valganciclovir

Duration

Currently taking Valganciclovir

Duration Patients
1 - 2 years 2
2 - 5 years 1
5 - 10 years 1

Stopped taking Valganciclovir

Duration Patients
Less than 1 month 3
1 - 6 months 22
6 months - 1 year 8
1 - 2 years 4
2 - 5 years 2
Adherence
Adherence Evaluations
Always 30
Usually 0
Sometimes 0
Never taken as prescribed 3
Burden
Burden Evaluations
Very hard to take 1
Somewhat hard to take 2
A little hard to take 1
Not at all hard to take 29
Cost per month
Cost per month Evaluations
$200+ 2
$100-199 2
$50-99 2
$25-49 2
< $25 10
Not specified 15

What people switch to and from

Patients started taking Valganciclovir after stopping:

Treatment Patients
Ganciclovir 1
Last updated:

8 patient evaluations for Valganciclovir

Oct 30, 2013 (Started Jun 19, 2009)

  • Effectiveness
    Major (for cytomegalovirus (CMV) retinitis)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 450 mg Daily
Cost: < $25 monthly

  • 0 helpful marks

Jun 1, 2013 (Started Jan 31, 2013)

  • Effectiveness
    None (for Prevent infection)
  • Side effects
    None
  • Adherence
    Never taken as prescribed
  • Burden
    Not at all hard to take
Dosage: 450 mg Daily

  • 0 helpful marks

Apr 13, 2013 (Started Oct 10, 2012)

  • Effectiveness
    Moderate (for Prevent infection)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: 900 mg Daily
Cost: < $25 monthly

  • 0 helpful marks
Last updated:
Showing 3 of 8 patient evaluations for Valganciclovir